How Much Does Vardenafil (Levitra/Staxyn) Cost in Hawaii in 2026?

Hawaii Retail Pricing for Vardenafil in 2026

The average cash-pay price for generic vardenafil across Hawaii retail pharmacies sits near $120 per month in 2026. That figure reflects a 30-tablet supply at 20 mg, the most commonly prescribed strength. Brand-name Levitra carries a manufacturer list price of $350 per month from Bayer, though very few patients pay that number out of pocket once insurance adjustments or discount cards are applied.

Hawaii's pharmacy market is shaped by geography. Most independent pharmacies on neighbor islands carry smaller inventories and may price generics slightly above Oahu averages. Costco Pharmacy locations in Honolulu and Maui tend to offer the lowest per-tablet pricing for generic vardenafil without requiring a membership for pharmacy services. Walmart and CVS locations across the state generally price generic vardenafil between $3.50 and $5.00 per tablet at cash-pay rates.

Vardenafil received FDA approval in August 2003 as a selective PDE5 inhibitor for erectile dysfunction. The key trial by Porst et al. (2003) demonstrated that vardenafil 20 mg improved erectile function domain scores by 7.7 points over placebo on the International Index of Erectile Function (IIEF), with 80% of intercourse attempts successful at that dose. Generic formulations entered the U.S. market after patent expiration, driving per-tablet costs down by roughly 65% from peak brand pricing.

Staxyn, the orally disintegrating tablet (ODT) formulation at 10 mg, remains slightly more expensive than conventional tablets. Expect to pay $140 to $180 per month for Staxyn at Hawaii retail pharmacies if paying cash.

Hawaii Medicaid and Vardenafil Coverage

Hawaii Medicaid does not cover vardenafil for erectile dysfunction. This exclusion applies across all Hawaii Medicaid managed care plans, including AlohaCare, HMSA, Kaiser Permanente Hawaii, Ohana Health Plan, and UnitedHealthcare Community Plan.

The exclusion is consistent with how most state Medicaid programs treat PDE5 inhibitors. After the Deficit Reduction Act of 2005, the Centers for Medicare & Medicaid Services (CMS) allowed states to exclude drugs used for erectile dysfunction from Medicaid formularies, and federal guidance has maintained that position. Hawaii exercises this option. Even with a prior authorization request, vardenafil claims for ED are denied under Med-QUEST Division formulary rules.

There is one narrow exception. If a prescriber documents a non-ED indication with supporting clinical evidence (for example, pulmonary arterial hypertension, though sildenafil and tadalafil are standard for that condition), some managed care organizations may review the claim under a medical exception pathway. This route is rarely successful for vardenafil specifically, since it lacks an FDA-approved indication beyond ED and the Endocrine Society clinical practice guidelines do not recommend it for off-label vascular uses.

Patients enrolled in Hawaii Medicaid who need ED treatment can explore compounded alternatives through 503A pharmacies or use manufacturer savings programs to reduce out-of-pocket cost at retail.

Insurance Coverage Through Hawaii Commercial Plans

Most commercial insurance plans available on the Hawaii Health Connector marketplace or through employer-sponsored coverage include generic vardenafil on their formularies. Placement is typically Tier 2 (preferred brand) or Tier 3 (non-preferred brand), with copays ranging from $30 to $75 per fill.

HMSA, Hawaii's largest insurer, covers generic vardenafil on its PPO and HMO plans with a quantity limit of 8 to 12 tablets per 30-day fill period. Kaiser Permanente Hawaii covers it through its integrated pharmacy system at a $35 copay for most plans. UnitedHealthcare plans sold in Hawaii generally place generic vardenafil on Tier 2 with a $40 to $50 copay.

A few things affect your actual cost. Prior authorization is not universally required, but some plans mandate it for quantities above 8 tablets per month. Step therapy protocols may require documentation that sildenafil (typically the cheapest PDE5 inhibitor) was tried first or is contraindicated. If your plan requires step therapy, your prescriber can submit a formulary exception by documenting adverse effects from sildenafil or a clinical rationale for vardenafil, such as the faster onset demonstrated in clinical data (median 25 minutes to onset) or the lower rate of visual disturbance compared to sildenafil.

Brand-name Levitra and Staxyn are increasingly excluded from commercial formularies or placed on specialty tiers with $100+ copays. Unless your plan specifically covers the brand, generic vardenafil is the financially rational choice.

Compounded Vardenafil in Hawaii

Compounded vardenafil is legal in Hawaii through 503A-licensed pharmacies operating under individual patient prescriptions. Section 503A of the Federal Food, Drug, and Cosmetic Act permits licensed pharmacists to compound medications when a prescriber writes a patient-specific prescription and the compounded product is not a copy of a commercially available drug in the same dosage form and strength.

Hawaii's Board of Pharmacy regulates compounding under Hawaii Administrative Rules Title 16, Chapter 95. 503A pharmacies in the state must comply with United States Pharmacopeia (USP) Chapter 795 standards for non-sterile compounding.

The practical reality: compounded vardenafil is typically available as troches, sublingual tablets, or combination formulations (often paired with tadalafil or sildenafil at sub-therapeutic doses). Pricing from Hawaii-based and mainland 503A pharmacies that ship to the state ranges from $45 to $90 per month, depending on the dosage form and compounding pharmacy.

One consideration. The FDA's position on compounding is that 503A products should fill a medical need not met by commercially available products. Because generic vardenafil tablets are commercially available and affordable, some pharmacy compliance experts argue that compounding the same oral tablet form at the same strength may not meet 503A requirements. Combination formulations or alternative delivery methods (sublingual, troche) have a stronger legal footing because they differ meaningfully from commercial products.

Patients considering compounded vardenafil should verify that the pharmacy holds a current Hawaii state license and ask whether the pharmacy undergoes voluntary accreditation through the Pharmacy Compounding Accreditation Board (PCAB).

Telehealth Prescribing in Hawaii

Hawaii fully permits telehealth prescribing of vardenafil. The state expanded telehealth access through Act 226 (2016), and subsequent legislative updates during and after the COVID-19 public health emergency made audio-video telehealth encounters a permanent prescribing pathway for most medications, including PDE5 inhibitors.

A prescriber licensed in Hawaii (or holding an active license through the Interstate Medical Licensure Compact, which Hawaii joined) can evaluate a patient via synchronous video visit, confirm that vardenafil is appropriate given the patient's cardiovascular history and medication list, and transmit an electronic prescription to any Hawaii pharmacy.

Several national telehealth platforms operate in Hawaii and prescribe vardenafil. HealthRX, Hims, Ro, and Lemonaid Health all serve Hawaii ZIP codes. Pricing through telehealth platforms varies. Consultation fees typically range from $0 (bundled into medication cost) to $75 per visit. Some platforms offer monthly subscription models that include the medication and ongoing clinical oversight.

The American Urological Association (AUA) guidelines on erectile dysfunction support the use of PDE5 inhibitors as first-line pharmacotherapy and do not require in-person examination as a prerequisite for prescribing when clinical history is adequately obtained.

Telehealth visits for vardenafil should include a medication reconciliation step. Vardenafil is contraindicated with nitrates (nitroglycerin, isosorbide mononitrate, isosorbide dinitrate) and potent CYP3A4 inhibitors like ketoconazole and ritonavir. Alpha-blockers require dose adjustment. A prescriber who skips medication reconciliation during a telehealth visit is cutting a corner that carries real hemodynamic risk.

How to Lower Your Vardenafil Cost in Hawaii

Multiple strategies can reduce what you pay.

Use generic vardenafil, not brand Levitra. The chemical is identical. Bioequivalence is required by FDA for generic approval. The price difference is $230 per month or more.

Apply a manufacturer savings card. Bayer's Levitra savings card (for the brand) and various generic manufacturer discount cards can reduce copays by $20 to $50 per fill. These cards do not work with Medicaid or other government insurance.

Check GoodRx, RxSaver, or SingleCare pricing. Discount aggregator platforms negotiate contracted rates with pharmacy benefit managers. In Hawaii, these platforms frequently show generic vardenafil at $60 to $90 for a 10-tablet supply at participating pharmacies. Costco and Safeway locations on Oahu consistently appear among the lowest-priced options.

Ask about pill splitting. Vardenafil 20 mg tablets can be split to yield two 10 mg doses if your prescribed dose is 10 mg. This effectively halves per-dose cost. The FDA-approved labeling lists 10 mg as the recommended starting dose for most patients. Note: Staxyn ODT tablets cannot be split. Only conventional film-coated tablets are appropriate for splitting.

Explore 503A compounding. As discussed above, compounded vardenafil formulations may cost $45 to $90 per month, potentially less than retail generic pricing depending on the pharmacy and formulation.

Use your FSA or HSA. Vardenafil prescribed for erectile dysfunction is a qualified medical expense under IRS rules for Flexible Spending Accounts and Health Savings Accounts. This effectively provides a tax discount equal to your marginal tax rate. Hawaii has no state income tax on HSA contributions that follow federal tax treatment, so the combined federal-plus-state benefit can reduce effective cost by 22% to 37% depending on your bracket.

Vardenafil vs. Other PDE5 Inhibitors: Cost Comparison in Hawaii

Hawaii pricing follows national trends but with modest island-market premiums on some generics due to distribution costs. Here is how vardenafil compares to other PDE5 inhibitors at cash-pay retail prices in Hawaii (2026 estimates, 30-tablet supply).

Generic sildenafil (Viagra equivalent) runs approximately $30 to $50 per month, making it the cheapest PDE5 option. Generic tadalafil (Cialis equivalent) costs roughly $40 to $70 per month for on-demand use, with daily 5 mg dosing priced similarly. Generic vardenafil at $120 per month is the most expensive of the three common generics. Avanafil (Stendra) remains brand-only at $350 to $500 per month.

The cost differential matters. If price is the primary concern and you have no clinical reason to prefer vardenafil, generic sildenafil is four times cheaper. The clinical data from Porst et al. showed vardenafil's efficacy profile is comparable to sildenafil, with a marginally faster median onset and a meta-analysis published in the Journal of Sexual Medicine suggesting a slight advantage in patients with diabetes. These differences may justify the cost for specific patients but do not represent a blanket reason to choose vardenafil over sildenafil.

If you have tried sildenafil and experienced visual side effects (blue-tinted vision occurs in roughly 3% of patients due to PDE6 cross-reactivity), vardenafil has lower PDE6 affinity and may be a better-tolerated alternative. Document this in your medical record; it strengthens insurance exception requests.

Military and VA Coverage in Hawaii

Active-duty service members and veterans in Hawaii have distinct coverage pathways. TRICARE covers generic vardenafil under its pharmacy benefit, typically at $13 for a 90-day supply through TRICARE mail-order pharmacy and $14 at a TRICARE retail network pharmacy. Quantity limits apply (typically 6 tablets per 30 days).

The VA National Formulary includes sildenafil as the preferred PDE5 inhibitor. Vardenafil is available as a non-formulary request when sildenafil is ineffective or not tolerated. VA copays for a 30-day supply are $5 for veterans in Priority Groups 1 through 6. For the roughly 130,000 veterans living in Hawaii, the VA Pacific Islands Health Care System (VAPIHCS) facilities on Oahu dispense medications at these formulary copay rates.

Medicare Part D and Vardenafil in Hawaii

Like Medicaid, Medicare Part D plans can exclude drugs used for ED from coverage. Most Part D plans sold in Hawaii do exclude vardenafil. The CMS Medicare Part D formulary guidance allows but does not require this exclusion.

A small number of Medicare Advantage plans with enhanced drug benefits (MA-PD plans) include PDE5 inhibitors as a supplemental benefit. For 2026, check the plan's Evidence of Coverage document or use the Medicare Plan Finder to verify formulary inclusion before enrolling. Humana and some AARP Medicare Complete plans have historically included limited PDE5 coverage in select markets.

Patients on Medicare who pay cash for vardenafil cannot apply the expense toward their Part D out-of-pocket maximum, since excluded drugs do not count toward catastrophic coverage thresholds.